Implementation of core outcome sets will help to ensure that critically important outcomes are consistently measured and reported in trials. Endorsement of the SONG outcomes is sought among key stakeholder organisations to support the use of core outcomes in trials in people with chronic kidney disease. This can help to improve the relevance and value of trials for informing decision-making among patients with chronic kidney disease and their healthcare providers.
Organisations that endorse the SONG outcome domains provide in-principle agreement of the following:
Australian and New Zealand Society of Nephrology (ANZSN) – Letter of endorsement
Australasian Kidney Trials Network (AKTN) – Letter of endorsement
Canadian Society of Nephrology (CSN) – Letter of endorsement
Canadian Society of Transplantation (CST)
Cochrane Kidney and Transplant (CKT) – Letter of endorsement
DaVita Kidney Care – Letter of endorsement
European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)
European Renal Best Practice (ERBP) – Letter of endorsement
Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INICRCT)
International Pediatric Transplant Assocation (IPTA) – Letter of endorsement
International Society of Nephrology (ISN) – Letter of endorsement
Kidney Disease Improving Global Outcomes (KDIGO) – Letter of endorsement
Kidney Health Australia – Caring for Australasians with Renal Impairment (KHA-CARI) – Letter of endorsement
PKD International (PKD Int)
Renal Association UK (RA)
The Transplantation Society (TTS) – Letter of endorsement
The Transplantation Society of Australia and New Zealand (TSANZ) – Letter of endorsement